Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis

Volume: 76, Pages: 144 - 156
Published: Jan 1, 2016
Abstract
In liver fibrosis, secretion of growth factors and hedgehog (Hh) ligands by hepatic parenchyma upon repeated insults results in transdifferentiation of quiescent hepatic stellate cells (HSCs) into active myofibroblasts which secrete excessive amounts of extracellular matrix (ECM) proteins. An Hh inhibitor GDC-0449 and miR-29b1 can play an important role in treating liver fibrosis by inhibiting several pro-fibrotic genes. Our in-silico analysis...
Paper Details
Title
Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis
Published Date
Jan 1, 2016
Volume
76
Pages
144 - 156
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.